BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35406751)

  • 1. GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation.
    Biagioli M; Marchianò S; Roselli R; Di Giorgio C; Bellini R; Bordoni M; Distrutti E; Catalanotti B; Zampella A; Graziosi L; Donini A; Fiorucci S
    Cells; 2022 Apr; 11(7):. PubMed ID: 35406751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Bile Acid Receptor GPBAR1 Regulates the M1/M2 Phenotype of Intestinal Macrophages and Activation of GPBAR1 Rescues Mice from Murine Colitis.
    Biagioli M; Carino A; Cipriani S; Francisci D; Marchianò S; Scarpelli P; Sorcini D; Zampella A; Fiorucci S
    J Immunol; 2017 Jul; 199(2):718-733. PubMed ID: 28607110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr
    Patel A; Yusta B; Matthews D; Charron MJ; Seeley RJ; Drucker DJ
    Mol Metab; 2018 Oct; 16():45-54. PubMed ID: 29937214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon.
    Verstockt B; Verstockt S; Abdu Rahiman S; Ke BJ; Arnauts K; Cleynen I; Sabino J; Ferrante M; Matteoli G; Vermeire S
    J Crohns Colitis; 2021 Mar; 15(3):485-498. PubMed ID: 32915959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease.
    Potdar AA; Dube S; Naito T; Li K; Botwin G; Haritunians T; Li D; Casero D; Yang S; Bilsborough J; Perrigoue JG; Denson LA; Daly M; Targan SR; Fleshner P; Braun J; Kugathasan S; Stappenbeck TS; McGovern DPB
    Gastroenterology; 2021 Feb; 160(3):809-822.e7. PubMed ID: 33160965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic bile acid sensing by G protein-coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP-1 release.
    Ullmer C; Alvarez Sanchez R; Sprecher U; Raab S; Mattei P; Dehmlow H; Sewing S; Iglesias A; Beauchamp J; Conde-Knape K
    Br J Pharmacol; 2013 Jun; 169(3):671-84. PubMed ID: 23488746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein-Coupled Bile Acid Receptors.
    Brighton CA; Rievaj J; Kuhre RE; Glass LL; Schoonjans K; Holst JJ; Gribble FM; Reimann F
    Endocrinology; 2015 Nov; 156(11):3961-70. PubMed ID: 26280129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-Cell Differentiation Is Induced by Bile Acids Through GPBAR1 and Paracrine GLP-1 and Serotonin Signaling.
    Lund ML; Sorrentino G; Egerod KL; Kroone C; Mortensen B; Knop FK; Reimann F; Gribble FM; Drucker DJ; de Koning EJP; Schoonjans K; Bäckhed F; Schwartz TW; Petersen N
    Diabetes; 2020 Apr; 69(4):614-623. PubMed ID: 32041793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic insights into the detection of free fatty and bile acids by ileal glucagon-like peptide-1 secreting cells.
    Goldspink DA; Lu VB; Billing LJ; Larraufie P; Tolhurst G; Gribble FM; Reimann F
    Mol Metab; 2018 Jan; 7():90-101. PubMed ID: 29167062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease.
    Biagioli M; Marchianò S; Di Giorgio C; Bordoni M; Urbani G; Bellini R; Massa C; Sami Ullah Khan R; Roselli R; Chiara Monti M; Morretta E; Giordano A; Vellecco V; Bucci M; Jilani Iqbal A; Saviano A; Ab Mansour A; Ricci P; Distrutti E; Zampella A; Cieri E; Cirino G; Fiorucci S
    Biochem Pharmacol; 2023 Dec; 218():115900. PubMed ID: 37926268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis.
    Carino A; Marchianò S; Biagioli M; Bucci M; Vellecco V; Brancaleone V; Fiorucci C; Zampella A; Monti MC; Distrutti E; Fiorucci S
    FASEB J; 2019 Feb; 33(2):2809-2822. PubMed ID: 30303744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1.
    Renga B; Cipriani S; Carino A; Simonetti M; Zampella A; Fiorucci S
    PLoS One; 2015; 10(11):e0141082. PubMed ID: 26539823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1.
    Biagioli M; Carino A; Marchianò S; Roselli R; Di Giorgio C; Bordoni M; Fiorucci C; Sepe V; Conflitti P; Limongelli V; Distrutti E; Baldoni M; Zampella A; Fiorucci S
    Biochem Pharmacol; 2020 Jul; 177():113987. PubMed ID: 32330496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells.
    Habib AM; Richards P; Rogers GJ; Reimann F; Gribble FM
    Diabetologia; 2013 Jun; 56(6):1413-6. PubMed ID: 23519462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor α decreases glucagon-like peptide-2 expression by up-regulating G-protein-coupled receptor 120 in Crohn disease.
    Tsukahara T; Watanabe K; Watanabe T; Yamagami H; Sogawa M; Tanigawa T; Shiba M; Tominaga K; Fujiwara Y; Maeda K; Hirakawa K; Arakawa T
    Am J Pathol; 2015 Jan; 185(1):185-96. PubMed ID: 25447053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colonic inflammation induces changes in glucose levels through modulation of incretin system.
    Zatorski H; Salaga M; Zielińska M; Mokrowiecka A; Jacenik D; Krajewska WM; Małecka-Panas E; Fichna J
    Pharmacol Rep; 2021 Dec; 73(6):1670-1679. PubMed ID: 34535873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G protein-coupled receptor 40 activation ameliorates dextran sulfate sodium-induced colitis in mice via the upregulation of glucagon-likepeptide-2.
    Kato S; Utsumi D; Matsumoto K
    J Pharmacol Sci; 2019 Jun; 140(2):144-152. PubMed ID: 31242961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased colonic expression of ACE2 associates with poor prognosis in Crohn's disease.
    Toyonaga T; Araba KC; Kennedy MM; Keith BP; Wolber EA; Beasley C; Steinbach EC; Schaner MR; Jain A; Long MD; Barnes EL; Herfarth HH; Isaacs KL; Hansen JJ; Kapadia MR; Guillem JG; Gulati AS; Sethupathy P; Furey TS; Ehre C; Sheikh SZ
    Sci Rep; 2021 Jun; 11(1):13533. PubMed ID: 34188154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPBAR1 Functions as Gatekeeper for Liver NKT Cells and provides Counterregulatory Signals in Mouse Models of Immune-Mediated Hepatitis.
    Biagioli M; Carino A; Fiorucci C; Marchianò S; Di Giorgio C; Roselli R; Magro M; Distrutti E; Bereshchenko O; Scarpelli P; Zampella A; Fiorucci S
    Cell Mol Gastroenterol Hepatol; 2019; 8(3):447-473. PubMed ID: 31226434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-storage and release of insulin-like peptide-5, glucagon-like peptide-1 and peptideYY from murine and human colonic enteroendocrine cells.
    Billing LJ; Smith CA; Larraufie P; Goldspink DA; Galvin S; Kay RG; Howe JD; Walker R; Pruna M; Glass L; Pais R; Gribble FM; Reimann F
    Mol Metab; 2018 Oct; 16():65-75. PubMed ID: 30104166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.